Our study is the first to demonstrate the cellular and subcellular localizations and offer in vivo evidence for GRK2 activation as an early sign of cerebrovascular aging complications in age-associated diseases involving cerebrovascular abnormalities, neurodegeneration, and cognitive impairment before any amyloid deposition can be seen. Here, GRK2 is linked to amyloidosis.